Terms: = Prostate cancer AND BCL6, BCL5, 603, 604, ENSG00000113916, ZBTB27, P41182, LAZ3, BCL6A, ZNF51 AND Diagnosis
49 results:
1. Medication-based Comorbidity Measures and prostate cancer Treatment Selection.
Tiruye T; O'Callaghan M; FitzGerald LM; Moretti K; Jay A; Higgs B; Kichenadasse G; Caughey G; Roder D; Beckmann K
Clin Genitourin Cancer; 2024 Apr; 22(2):599-609.e2. PubMed ID: 38369388
[TBL] [Abstract] [Full Text] [Related]
2. Prediction of clinically significant prostate cancer through urine metabolomic signatures: A large-scale validated study.
Huang HP; Chen CH; Chang KH; Lee MS; Lee CF; Chao YH; Lu SY; Wu TF; Liang ST; Lin CY; Lin YC; Liu SP; Lu YC; Shun CT; Huang WJ; Lin TP; Ku MH; Chung HJ; Chang YH; Liao CH; Yu CC; Chung SD; Tsai YC; Wu CC; Chen KC; Ho CH; Hsiao PW; Pu YS
J Transl Med; 2023 Oct; 21(1):714. PubMed ID: 37821919
[TBL] [Abstract] [Full Text] [Related]
3. Pretest Video Education Versus Genetic Counseling for Patients With prostate cancer: ProGen, A Multisite Randomized Controlled Trial.
Rana HQ; Stopfer JE; Weitz M; Kipnis L; Koeller DR; Culver S; Mercado J; Gelman RS; Underhill-Blazey M; McGregor BA; Sweeney CJ; Petrucelli N; Kokenakes C; Pirzadeh-Miller S; Reys B; Frazier A; Knechtl A; Fateh S; Vatnick DR; Silver R; Kilbridge KE; Pomerantz MM; Wei XX; Choudhury AD; Sonpavde GP; Kozyreva O; Lathan C; Horton C; Dolinsky JS; Heath EI; Ross TS; Courtney KD; Garber JE; Taplin ME
JCO Oncol Pract; 2023 Nov; 19(11):1069-1079. PubMed ID: 37733980
[TBL] [Abstract] [Full Text] [Related]
4. Pain and its interference with daily living in relation to cancer: a comparative population-based study of 16,053 cancer survivors and 106,345 people without cancer.
Joshy G; Khalatbari-Soltani S; Soga K; Butow P; Laidsaar-Powell R; Koczwara B; Rankin NM; Brown S; Weber M; Mazariego C; Grogan P; Stubbs J; Thottunkal S; Canfell K; Blyth FM; Banks E
BMC Cancer; 2023 Sep; 23(1):774. PubMed ID: 37700229
[TBL] [Abstract] [Full Text] [Related]
5. prostate cancer detection and segmentation on MRI using non-local mask R-CNN with histopathological ground truth.
Dai Z; Jambor I; Taimen P; Pantelic M; Elshaikh M; Dabaja A; Rogers C; Ettala O; Boström PJ; Aronen HJ; Merisaari H; Wen N
Med Phys; 2023 Dec; 50(12):7748-7763. PubMed ID: 37358061
[TBL] [Abstract] [Full Text] [Related]
6. Comparing Risk for Second Primary cancers After Intensity-Modulated vs 3-Dimensional Conformal Radiation Therapy for prostate cancer, 2002-2015.
Pithadia KJ; Advani PG; Citrin DE; Bekelman JE; Withrow DR; Berrington de Gonzalez A; Morton LM; Schonfeld SJ
JAMA Oncol; 2023 Aug; 9(8):1119-1123. PubMed ID: 37289449
[TBL] [Abstract] [Full Text] [Related]
7. Post-transplant diabetes mellitus and renal cell cancer after renal transplantation.
Porrini E; Montero N; Díaz JM; Lauzurrica R; Rodríguez JO; Torres IS; Moreso F; Cruzado JM; Ruiz RB; Vilaró MI; Lima MXM; Ramchand SK; Ruiz JC; Gainza de Los Rios F; Alvarez CR; Guindo MDCG; Macías M; Vela DB; Osuna A; Bayés-Genís B; Sanchez CA; Ruiz MDC; Rodríguez AER; Rollán RD; Rinne FG; Sosa AJ; Mallén PD; Rinne AG; Miranda DM; Torres A
Nephrol Dial Transplant; 2023 May; 38(6):1552-1559. PubMed ID: 36323457
[TBL] [Abstract] [Full Text] [Related]
8. Intravascular large B cell lymphoma of prostate, a rare entity.
Rallabandi HB; Thirukovela J; Swain M; Meeramira D; Gowrishankar S
Indian J Pathol Microbiol; 2021; 64(3):575-578. PubMed ID: 34341277
[TBL] [Abstract] [Full Text] [Related]
9. Role of PCA3 and SelectMDx in the optimization of active surveillance in prostate cancer.
Fiorella D; Marenco JL; Mascarós JM; Borque-Fernando Á; Esteban LM; Calatrava A; Pastor B; López-Guerrero JA; Rubio-Briones J
Actas Urol Esp (Engl Ed); 2021; 45(6):439-446. PubMed ID: 34148844
[TBL] [Abstract] [Full Text] [Related]
10. Ten-year cardiovascular risk among cancer survivors: The National Health and Nutrition Examination Survey.
Zhang X; Pawlikowski M; Olivo-Marston S; Williams KP; Bower JK; Felix AS
PLoS One; 2021; 16(3):e0247919. PubMed ID: 33661978
[TBL] [Abstract] [Full Text] [Related]
11. Acute myocardial infarction treatments and outcomes in 6.5 million patients with a current or historical diagnosis of cancer in the USA.
Bharadwaj A; Potts J; Mohamed MO; Parwani P; Swamy P; Lopez-Mattei JC; Rashid M; Kwok CS; Fischman DL; Vassiliou VS; Freeman P; Michos ED; Mamas MA
Eur Heart J; 2020 Jun; 41(23):2183-2193. PubMed ID: 31800032
[TBL] [Abstract] [Full Text] [Related]
12. Who Dies From prostate cancer? An Analysis of the Surveillance, Epidemiology and End Results Database.
Roy S; Morgan SC
Clin Oncol (R Coll Radiol); 2019 Sep; 31(9):630-636. PubMed ID: 31130340
[TBL] [Abstract] [Full Text] [Related]
13. Comparison of PET/MRI with multiparametric MRI in diagnosis of primary prostate cancer: A meta-analysis.
Li M; Huang Z; Yu H; Wang Y; Zhang Y; Song B
Eur J Radiol; 2019 Apr; 113():225-231. PubMed ID: 30927951
[TBL] [Abstract] [Full Text] [Related]
14. The International Society of Urological Pathology Education web-a web-based system for training and testing of pathologists.
Egevad L; Delahunt B; Samaratunga H; Leite KR; Efremov G; Furusato B; Han M; Jufe L; Tsuzuki T; Wang Z; Hörnblad J; Clements M
Virchows Arch; 2019 May; 474(5):577-584. PubMed ID: 30790058
[TBL] [Abstract] [Full Text] [Related]
15. Association of Care at Minority-Serving vs Non-Minority-Serving Hospitals With Use of Palliative Care Among Racial/Ethnic Minorities With Metastatic cancer in the United States.
Cole AP; Nguyen DD; Meirkhanov A; Golshan M; Melnitchouk N; Lipsitz SR; Kilbridge KL; Kibel AS; Cooper Z; Weissman J; Trinh QD
JAMA Netw Open; 2019 Feb; 2(2):e187633. PubMed ID: 30707230
[TBL] [Abstract] [Full Text] [Related]
16. Interventions for promoting habitual exercise in people living with and beyond cancer.
Turner RR; Steed L; Quirk H; Greasley RU; Saxton JM; Taylor SJ; Rosario DJ; Thaha MA; Bourke L
Cochrane Database Syst Rev; 2018 Sep; 9(9):CD010192. PubMed ID: 30229557
[TBL] [Abstract] [Full Text] [Related]
17. Statin use and time to progression in men on active surveillance for prostate cancer.
Jayalath VH; Nayan M; Finelli A; Komisarenki M; Timilshina N; Kulkarni GS; Fleshner NE; Bhindi B; Evans A; Zlotta AR; Hamilton RJ
Prostate Cancer Prostatic Dis; 2018 Nov; 21(4):509-515. PubMed ID: 29875433
[TBL] [Abstract] [Full Text] [Related]
18. The Effect of Including Bone in Dixon-Based Attenuation Correction for
Elschot M; Selnæs KM; Johansen H; Krüger-Stokke B; Bertilsson H; Bathen TF
J Nucl Med; 2018 Dec; 59(12):1913-1917. PubMed ID: 29728516
[TBL] [Abstract] [Full Text] [Related]
19. Characteristics of people living in Italy after a cancer diagnosis in 2010 and projections to 2020.
Guzzinati S; Virdone S; De Angelis R; Panato C; Buzzoni C; Capocaccia R; Francisci S; Gigli A; Zorzi M; Tagliabue G; Serraino D; Falcini F; Casella C; Russo AG; Stracci F; Caruso B; Michiara M; Caiazzo AL; Castaing M; Ferretti S; Mangone L; Rudisi G; Sensi F; Mazzoleni G; Pannozzo F; Tumino R; Fusco M; Ricci P; Gola G; Giacomin A; Tisano F; Candela G; Fanetti AC; Pala F; Sardo AS; Rugge M; Botta L; Dal Maso L
BMC Cancer; 2018 Feb; 18(1):169. PubMed ID: 29426306
[TBL] [Abstract] [Full Text] [Related]
20. The establishment and evaluation of a new model for the prediction of prostate cancer.
Wang Q; Li YF; Jiang J; Zhang Y; Liu XD; Li K
Medicine (Baltimore); 2017 Mar; 96(11):e6138. PubMed ID: 28296726
[TBL] [Abstract] [Full Text] [Related]
[Next]